Dr. Gene Cefali, Pharm.D., Ph.D. is a drug development consultant assisting early-stage pharmaceutical companies with drug development strategy and execution as well as providing pharmaceutical due-diligence expertise to investment companies and the pharmaceutical industry since 2007. Prior to this, Dr. Cefali held positions of increasing responsibility at Kos Pharmaceuticals (acquired by Abbott Laboratories), culminating with the position of Vice President of Lead Optimization. Dr. Cefali is a co-inventor on seven patents as well as an author of many pharmacokinetics manuscripts. Dr. Cefali specialises in assisting early-stage pharmaceutical companies with drug development strategy and execution as well as providing pharmaceutical due-diligence expertise to investment companies and pharmaceuticals industry since 2007. He has a proven track record of using his biopharmaceutics and drug development knowledge to significantly add value to a drug venture’s potential success. Dr. Gene Cefali, Pharm.D., Ph.D. is a drug development consultant assisting early-stage pharmaceutical companies with drug development strategy and execution as well as providing pharmaceutical due-diligence expertise to investment companies and the pharmaceutical industry since 2007. Prior to this, Dr. Cefali held positions of increasing responsibility at Kos Pharmaceuticals (acquired by Abbott Laboratories), culminating with the position of Vice President of Lead Optimization. Dr. Cefali is a co-inventor on seven patents as well as an author of many pharmacokinetics manuscripts. Dr. Cefali specialises in assisting early-stage pharmaceutical companies with drug development strategy and execution as well as providing pharmaceutical due-diligence expertise to investment companies and pharmaceuticals industry since 2007. He has a proven track record of using his biopharmaceutics and drug development knowledge to significantly add value to a drug venture’s potential success.

Pharmaceutical industry